Saturday, February 24, 2024
HomeHealthSupporting innovations in cancer treatment and prevention for our nation’s most vulnerable...

Supporting innovations in cancer treatment and prevention for our nation’s most vulnerable – The Health Care Blog

By KAT MCDAVITT and LESLIE KIRK

Innsena has made a $100,000 contribution to CancerX, making Innsena the first impact sponsor of the public-private partnership.

Because? There are few conditions under which the disparity in innovations that benefit underserved communities is more evident than in cancer treatment and prevention.

Uninsured patients are more likely to have more advanced cancers, and the cancer death rate among people of color is significantly higher than that of white patients. More people die from cancer in rural communities than in urban settings.

At CancerX, we find a community of partners tackling tough problems to equitably implement innovative solutions that can reduce the risk and cure cancer for all patients. Even (and especially) when there are no financial incentives for the private sector to solve those problems.

Innsena is committed to improving access, treatment and equitable outcomes for the most vulnerable among us. We focus on supporting better outcomes for Medicaid members and underserved communities. The disparity caused by the absence of incentives and funding for innovators to enter the Medicaid market cannot be understated.

But the innovators and investors funding these pioneers are exactly what our industry needs to change health outcomes in underserved communities.

We decided that if there are no incentives to innovate cancer care for vulnerable populations, then we would create them. Our financial commitment to CancerX is a step forward that we hope will start a broader movement.

Our team’s $100,000 contribution will help the CancerX team accelerate ongoing programs, including its effort to improve equity and reduce financial toxicity in cancer care and research, and launch new initiatives more quickly.

We are particularly proud to support public-private partnership efforts to improve equity and reduce financial toxicity. Cancer deaths are unevenly distributed in the United States, and patients who survive are 2.5 times more likely to declare bankruptcy than those who do not have the disease.

Additionally, a key component of CancerX is an accelerator for startups that offer more digital solutions for cancer treatment and prevention, with a focus on organizations focusing on underserved populations. We are honored to support the startups selected for the first cohort of the CancerX accelerator with mentorship and financial support.

And to do this, as individuals, we have taken another step to support startups focused on preventing and curing cancer in vulnerable patients. We’ve also partnered with Ben Freeberg and his team at Oncology Ventures to ensure digital health startups innovating for all patients in the oncology space have funding available to advance their causes.

Innsena joins more than 150 organizations already working together to make a difference for all patients in cancer prevention and treatment. CancerX is co-hosted by Moffitt Cancer Center and the Digital Medicine Society, along with the Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services.

We need more innovators working to improve care for the underserved. Please join us in supporting CancerX. As a community we will make a difference.

Kat McDavitt is President and Founding Partner of Innsena. Leslie Kirk is CEO and managing partner of Innsena.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments